Status in clinical application of brain natriuretic peptide

doi:10.3969/j.issn.1004-583X.2017.04.004

Clinical Focus

Previous Articles Next Articles

Status in clinical application of brain natriuretic peptide

1.Department of Laboratory Medicine， the Third Hospital of Hebei Medical University，
Shijiazhuang 050051，China; 2. Department of Laboratory Medicine， the Traditional Chinese
Medicine Hospital of Shijiazhuang， Shijiazhuang 050051， China

Online:2017-04-05 Published:2017-03-31
Contact: Corresponding author：Feng Zhongjun，Email：fzjdoc@163.com

Abstract

Abstract: Brain natriuretic peptide(BNP) is a biological marker for diagnosis of heart failure(HF)， it further shows a wide range of potential applications in prognosis and treatment in other diseases. Due to differences in various countries， a large prospective clinical research work should be done to further elucidate. BNP will play a more important role in the diagnosis and treatment of diseases， especially in HF.

Key words: natriuretic peptide, brain；heart failure；kidney disease；diabetes, type 2

Feng Zhongjun1， Zhang Shulan2. Status in clinical application of brain natriuretic peptide[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2017.04.004.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2017.04.004

https://huicui.hebmu.edu.cn/EN/Y2017/V32/I4/287

[1]	Zhang Jianan, Sun Linlin, Zhan Xiaoyan, Li Bing. Correlation between serum Vitamin B₁₂ and mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(1): 34-37.
[2]	Wei Zeng, Cao Ling, She Dunmin, Liu Yan, Wang Yan, Zhang Zhenwen. The causes of death in 54 patients with type 2 diabetes mellitus complicated with COVID-19 [J]. Clinical Focus, 2023, 38(9): 806-812.
[3]	Jin Jiahui, Yang Yang, Qin Tong, He Yuxin, Su Meihua. Probiotic supplementation on improving glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(7): 581-587.
[4]	Li Hengnan, Huang Yan, Zhao Yajuan, Hu Guicai. Correlation between serum CTRP5 and left ventricular diastolic dysfunction in patients with continuous ambulatory peritoneal dialysis and its diagnostic value [J]. Clinical Focus, 2023, 38(4): 324-329.
[5]	Yang Minxing, Sun Lu, Ye Yun, Xu Wendong, Huang Xiaolin, Zhang Haiyun, Xu Yinglei. Characteristics of cognitive function and corresponding factors in young and middle-aged patients with type 2 diabetes with obstructive sleep apnea hypopnea syndrome [J]. Clinical Focus, 2023, 38(3): 216-220.
[6]	Li Huifang, Miao Xia. Prediction of thyroid hormone level on risk of type 2 diabetes nephropathy [J]. Clinical Focus, 2023, 38(2): 137-142.
[7]	Zhu Chenglou, Wu Qiong, Da Mingxu. Risk assessment of pancreatic cancer in patients with type 2 diabetes mellitus treated with sitagliptin: A meta-analysis of randomized controlled trials [J]. Clinical Focus, 2023, 38(12): 1061-1066.
[8]	Liao Kunfeng, Yao Yisong, Yang Jinpan, Yang Xining, Li Yaru, Zhou Hongyan, Liang Piao. Status and influencing factors of fear of progression in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(12): 1095-1100.
[9]	Shi Peihua, Lin Yanlin, Bi Lifang. Study on the correlation of NLR, PLR and MLR with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2023, 38(11): 996-1001.
[10]	Xu Yang, Xue Ling. Influencing factors for mild cognitive impairment in type H hypertension patients combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(10): 887-892.
[11]	Xie Feifei, Zhang Weijian. Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(1): 20-36.
[12]	Wang Cui, Lin Hao, Wu Pingping, Zhang Yali, Ren Jian, Xu Ting, Dong Guoyu, Zai Guotian. Correlation between hyperhomocysteinemia and early renal disease in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 42-45.
[13]	Zhang Shangshi, Zhu Hongyan, Li Nan, Chen Yingxi. Correlation between coronary artery lesion and insulin resistance in patients with coronary heart disease combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 46-49.
[14]	Zhao Liyan, Kang wei, Wang Qingzhou, Li Bopeng, Cao Yawei, Li Junfen, Shao Liang, Wang Kang. Correlation analysis between lipid accumulation index and visceral fat index and glucose metabolism disorders in first-degree relatives of type 2 diabetes mellitus [J]. Clinical Focus, 2022, 37(9): 804-807.
[15]	Wang Zhenzhen, Zhao shiyi, Feng Siran, Ma Boqing. Predictive value of neutrophil to lymphocyte ratio for microalbuminuria of patients with type 2 diabetes mellitus [J]. Clinical Focus, 2022, 37(9): 808-812.

Status in clinical application of brain natriuretic peptide

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments